Retn (Resistin) induces insulin resistance in rodents, plays a role in atherosclerosis and cardiovascular disease, induces nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB) activity and activates MAPKs such as Erk or p38 and Akt (97). This evidence concerns the gene NFKB1 and Insulin resistance.